重组Anti-WSTF抗体[EP1704Y]
Anti-WSTF antibody [EP1704Y]
- RabMAb
- Recombinant
- KO Validated
- 了解详情
4
(2 Reviews)
|
(11 Publications)
Rabbit Recombinant Monoclonal WSTF antibody. Suitable for IHC-P, WB, ICC/IF, Flow Cyt (Intra) and reacts with Mouse, Rat, Human samples. Cited in 11 publications.
查看别名
WBSC10, WBSCR10, WBSCR9, WSTF, BAZ1B, Tyrosine-protein kinase BAZ1B, Bromodomain adjacent to zinc finger domain protein 1B, Williams syndrome transcription factor, Williams-Beuren syndrome chromosomal region 10 protein, Williams-Beuren syndrome chromosomal region 9 protein, hWALp2
- Flow Cyt (Intra)
Supplier Data
Flow Cytometry (Intracellular) - Anti-WSTF antibody [EP1704Y] (AB51256)
Flow Cytometry analysis of HeLa (Human cervix adenocarcinoma epithelial cell) cells labelling WSTF with Purified ab51256 at 1 : 20 dilution (10 µg/ml) (Red). Cells were fixed with 4% Paraformaldehyde and permeabilised with 90% Methanol. A Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) secondary antibody was used at 1 : 2000. Isotype control - Rabbit monoclonal IgG (Black). Unlabelled control - Cell without incubation with primary antibody and secondary antibody (Blue).
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-WSTF antibody [EP1704Y] (AB51256)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human breast carcinoma tissue sections labeling WSTF with Purified ab51256 at 1 : 700 dilution (0.211 µg/ml). Heat mediated antigen retrieval was performed using Heat mediated antigen retrieval using ab93678 (citrate buffer, pH 6.0). Tissue was counterstained with Hematoxylin. ImmunoHistoProbe one step HRP Polymer (ready to use) secondary antibody was used. PBS instead of the primary antibody was used as the negative control.
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-WSTF antibody [EP1704Y] (AB51256)
Immunocytochemistry analysis of HeLa (Human cervix adenocarcinoma epithelial cell) cells labeling WSTF with Purified ab51256 at 1 : 50 dilution (2.9 µg/ml). Cells were fixed in 4% Paraformaldehyde and permeabilized with 0.1% tritonX-100. Cells were counterstained with ab195889 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) 1 : 200 (2.5 µg/ml). Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) was used as the secondary antibody at 1 : 1000 (2 µg/ml) dilution. DAPI (blue) was used as nuclear counterstain. PBS instead of the primary antibody was used as the secondary antibody only control.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-WSTF antibody [EP1704Y] (AB51256)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of rat cardiac muscle tissue sections labeling WSTF with Purified ab51256 at 1 : 700 dilution (0.211 µg/ml). Heat mediated antigen retrieval was performed using Heat mediated antigen retrieval using ab93678 (citrate buffer, pH 6.0). Tissue was counterstained with Hematoxylin. ImmunoHistoProbe one step HRP Polymer (ready to use) secondary antibody was used. PBS instead of the primary antibody was used as the negative control.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-WSTF antibody [EP1704Y] (AB51256)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of mouse cardiac muscle tissue sections labeling WSTF with Purified ab51256 at 1 : 700 dilution (0.211 µg/ml). Heat mediated antigen retrieval was performed using Heat mediated antigen retrieval using ab93678 (citrate buffer, pH 6.0). Tissue was counterstained with Hematoxylin. ImmunoHistoProbe one step HRP Polymer (ready to use) secondary antibody was used. PBS instead of the primary antibody was used as the negative control.
- WB
Unknown
Western blot - Anti-WSTF antibody [EP1704Y] (AB51256)
Lanes 1 - 4 : Merged signal (red and green). Green - ab51256 observed at 175 kDa. Red - loading control, ab18058, observed at 124 kDa.
ab51265 was shown to recognize WSTF in wilt-type cells along with additional cross-reactive bands as signal was lost in WSTF knockout samples. Wild-type and WSTF knockout samples were subjected to SDS-PAGE. ab51256 and ab18058 (loading control to vinculin) were diluted 1/15 000 and 1/10 000 respectively and incubated overnight at 4°C. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1/10000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-WSTF antibody [EP1704Y] (ab51256) at 1/15000 dilution
Lane 1:
Wild-type HAP1 cell lysate at 20 µg
Lane 2:
WSTF knockout HAP1 cell lysate at 20 µg
Lane 3:
HeLa cell lysate at 20 µg
Lane 4:
PC12 cell lysate at 20 µg
Predicted band size: 171 kDa
false
- WB
Unknown
Western blot - Anti-WSTF antibody [EP1704Y] (AB51256)
Exposure time
Lane 1 : 10 seconds
Lane 2 : 40 seconds
Lane 3 : 180 seconds
All lanes:
Western blot - Anti-WSTF antibody [EP1704Y] (ab51256) at 1/5000 dilution
Lane 1:
B16-F0 (Mouse melanoma epithelial cell-like) whole cell lysate at 15 µg
Lane 2:
Mouse testis lysate at 15 µg
Lane 3:
Rat testis lysate at 15 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 171 kDa
Observed band size: 185 kDa
false
- WB
Unknown
Western blot - Anti-WSTF antibody [EP1704Y] (AB51256)
Exposure time :
Left image : 180 seconds
Right image : 40 seconds
We recommend to use ab109439 for WSTF Western Blot testing because ab51256 detects nonspecific bands.
All lanes:
Western blot - Anti-WSTF antibody [EP1704Y] (ab51256) at 1/20000 dilution
Lane 1:
HeLa (Human cervix adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 2:
T-47D (Human ductal breast epithelial tumor epithelial cell) whole cell lysate at 20 µg
Lane 3:
MCF7 (Human breast adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 171 kDa
false
- WB
Lab
Western blot - Anti-WSTF antibody [EP1704Y] (AB51256)
Lanes 1- 2 : Merged signal (red and green). Green - ab51256 observed at 175 kDa. Red - Anti-alpha Tubulin antibody [DM1A] - Loading Control (ab7291) observed at 50 kDa.
ab51256 was shown to react with WSTF in wild-type HeLa cells in western blot. Loss of signal was observed when knockout cell line ab264907 (knockout cell lysate ab257370) was used. Wild-type HeLa and WSTF knockout HeLa cell lysates were subjected to SDS-PAGE. Membrane was blocked for 1 hour at room temperature in 0.1% TBST with 3% non-fat dried milk. ab51256 and Anti-alpha Tubulin antibody [DM1A] - Loading Control (ab7291) overnight at 4°C at a 1 in 15000 dilution and a 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye®800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye®680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-WSTF antibody [EP1704Y] (ab51256) at 1/15000 dilution
Lane 1:
Wild-type HeLa cell lysate at 20 µg
Lane 2:
BAZ1B knockout HeLa cell lysate at 20 µg
Lane 2:
Western blot - Human BAZ1B (WSTF) knockout HeLa cell line (<a href='/products/cell-lines/human-baz1b-wstf-knockout-hela-cell-line-ab264907'>ab264907</a>)
Predicted band size: 171 kDa
Observed band size: 175 kDa
false
- WB
CiteAb
Western blot - Anti-WSTF antibody [EP1704Y] (AB51256)
WSTF western blot using anti-WSTF antibody [EP1704Y] ab51256. Publication image and figure legend from Liu, Y., Wang, S. Q., et al., 2016, Oncotarget, PubMed 27449290.
ab51256 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab51256 please see the product overview.
Release of WSTF was induced by KRASG12V in colon cells(A) We constructed the H-RasG12V expression vectors to preferentially activate the Ras pathways. The levels of P-ERK1/2, P-AKT and RalA-GTP were detected with specific antibodies to examine the activities of corresponding pathways. (B) Media containing WSTF and P-WSTF was detected using ELISA. Levels of intracellular P-WSTF, total WSTF protein and mRNA were detected as controls. (C) Different small interfering RNAs were transfected into HIPECKRASM cells for 48 h. Two specific siRNAs for each gene were implicated in experiments. The secreted WSTF was detected by ELISA assay. (D) The media of HIPECKRASM cells, which was cultured with U0126 (10 μM) or Wortmannin (10 μM) for 20 h, were tested by ELISA. Non-treated HIPECKRASM cells were used as control.
false
反应性数据
产品详情
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
性能和储存信息
形式
纯化工艺
存储溶液
运输条件
推荐的短期储存条件
推荐的长期储存条件
分装信息
储存信息
补充信息
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Since WSTF participates in chromatin structure modulation it plays a considerable role in transcriptional regulation. It is a part of the NURF complex which makes it essential for DNA accessibility and gene expression. The complex interacts with other proteins to allow chromatin to accommodate active transcription by repositioning nucleosomes. WSTF also has a kinase domain that phosphorylates histone H2A. This phosphorylation integrates signals that coordinate transcription and DNA damage repair mechanisms highlighting its multifunctional nature in maintaining genomic stability.
Pathways
WSTF has pivotal roles in the chromatin remodeling and DNA repair pathways. The chromatin remodeling pathway involves WSTF's interaction with the transcription factor complex influencing gene accessibility and expression. WSTF in the DNA repair pathway ensures proper genomic integrity through its association with proteins like BRCA1 highlighting its participation in the cellular response to DNA damage. By engaging with these pathways WSTF contributes to the cell's ability to regulate the genome and respond to damage efficiently.
产品实验方案
- Visit the General protocols
- Visit the Troubleshooting
靶点信息
文献 (11)
Recent publications for all applications. Explore the full list and refine your search
Nature communications 16:3709 PubMed40251151
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 15:10496 PubMed39627214
2024
Applications
Unspecified application
Species
Unspecified reactive species
Stem cells (Dayton, Ohio) 42:861-873 PubMed39169713
2024
Applications
Unspecified application
Species
Unspecified reactive species
BMC molecular biology 17:24 PubMed27938330
2016
Applications
WB
Species
Unspecified reactive species
Oncotarget 7:80901-80915 PubMed27779108
2016
Applications
WB
Species
Unspecified reactive species
Oncotarget 7:53153-53164 PubMed27449290
2016
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of neuroscience : the official journal of the Society for Neuroscience 36:3954-61 PubMed27053203
2016
Applications
Unspecified application
Species
Unspecified reactive species
Nature medicine 21:1146-53 PubMed26390241
2015
Applications
WB
Species
Unspecified reactive species
Nucleic acids research 42:6365-79 PubMed24753406
2014
Applications
ICC/IF
Species
Human
Nucleic acids research 39:8445-56 PubMed21745822
2011
Applications
WB
Species
Unspecified reactive species
Abcam Product Promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com